LeMaitre Vascular Company Profile (NASDAQ:LMAT)

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:LMAT
  • CUSIP: N/A
  • Web: www.lemaitre.com
  • Market Cap: $742.05 million
  • Outstanding Shares: 19,022,000
Average Prices:
  • 50 Day Moving Avg: $37.65
  • 200 Day Moving Avg: $32.08
  • 52 Week Range: $18.55 - $39.88
  • Trailing P/E Ratio: 54.821
  • Foreward P/E Ratio: 43.83
  • P/E Growth: 3.180
Sales & Book Value:
  • Annual Revenue: $96.4 million
  • Price / Sales: 7.70
  • Book Value: $5.20 per share
  • Price / Book: 7.50
  • Annual Dividend: $0.22
  • Dividend Yield: 0.6%
  • EBITDA: $23.12 million
  • Net Margins: 14.19%
  • Return on Equity: 15.02%
  • Return on Assets: 12.97%
  • Current Ratio: 7.25%
  • Quick Ratio: 5.07%
  • Average Volume: 188,505 shs.
  • Beta: 0.67
  • Short Ratio: 2.66

Frequently Asked Questions for LeMaitre Vascular (NASDAQ:LMAT)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Friday, July 28th. Shareholders of record on Wednesday, August 23rd will be given a dividend of $0.055 per share on Thursday, September 7th. This represents a $0.22 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Monday, August 21st. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its Board of Directors has authorized a stock repurchase program on Friday, July 28th 2017, which authorizes the company to repurchase $7,500,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 1.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its shares are undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted its earnings results on Thursday, July, 27th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. The company had revenue of $25.80 million for the quarter, compared to analysts' expectations of $25.42 million. LeMaitre Vascular had a return on equity of 15.02% and a net margin of 14.19%. The firm's revenue was up 15.2% compared to the same quarter last year. During the same period last year, the firm posted $0.14 earnings per share. View LeMaitre Vascular's Earnings History.

When will LeMaitre Vascular make its next earnings announcement?

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for LeMaitre Vascular.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular updated its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $0.79 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.70. The company issued revenue guidance of $101.9 million, compared to the consensus revenue estimate of $100.61 million.LeMaitre Vascular also updated its Q3 guidance to $0.20 EPS.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?

6 analysts have issued 12 month target prices for LeMaitre Vascular's shares. Their predictions range from $29.00 to $32.00. On average, they anticipate LeMaitre Vascular's stock price to reach $30.50 in the next year. View Analyst Ratings for LeMaitre Vascular.

What are analysts saying about LeMaitre Vascular stock?

Here are some recent quotes from research analysts about LeMaitre Vascular stock:

  • 1. According to Zacks Investment Research, "LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (9/28/2017)
  • 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)

Are investors shorting LeMaitre Vascular?

LeMaitre Vascular saw a increase in short interest during the month of September. As of September 29th, there was short interest totalling 921,148 shares, an increase of 32.0% from the September 15th total of 698,040 shares. Based on an average trading volume of 148,845 shares, the days-to-cover ratio is presently 6.2 days. Currently, 6.3% of the shares of the stock are short sold.

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

  • George W. LeMaitre, Chairman of the Board, Chief Executive Officer
  • David B. Roberts, President, Director
  • Joseph P. Pellegrino Jr., Chief Financial Officer, Director
  • Peter R. Gebauer, President - International Operations
  • Trent G. Kamke, Senior Vice President - Operations
  • Cornelia W. LeMaitre, Vice President - Human Resources
  • Lawrence J. Jasinski, Independent Director
  • John J. O'Connor, Independent Director
  • John A. Roush, Independent Director
  • Michael H. Thomas, Independent Director

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by many different of retail and institutional investors. Top institutional investors include Eqis Capital Management Inc. (0.07%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was acquired by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for LeMaitre Vascular.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LeMaitre Vascular stock can currently be purchased for approximately $39.01.

MarketBeat Community Rating for LeMaitre Vascular (NASDAQ LMAT)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  229 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  349
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $30.50 (21.81% downside)
Consensus Price Target History for LeMaitre Vascular (NASDAQ:LMAT)
Price Target History for LeMaitre Vascular (NASDAQ:LMAT)
Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/9/2017Canaccord GenuityReiterated RatingHold$30.00N/AView Rating Details
7/30/2017Stifel NicolausReiterated RatingBuy$29.00 -> $32.00HighView Rating Details
7/28/2017Benchmark Co.UpgradeHold -> BuyLowView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
3/21/2017First AnalysisInitiated CoverageOverweight -> Overweight$29.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Earnings History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.20N/AView Earnings Details
7/27/2017Q2 2017$0.17$0.23$25.42 million$25.80 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.13$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
2017 EPS Consensus Estimate: $0.67
2018 EPS Consensus Estimate: $0.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.13$0.14$0.13
Q2 20173$0.17$0.17$0.17
Q3 20173$0.17$0.20$0.18
Q4 20173$0.18$0.19$0.19
Q1 20182$0.19$0.19$0.19
Q2 20182$0.20$0.20$0.20
Q3 20181$0.20$0.20$0.20
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)


Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)
Most Recent Dividend:9/7/2017
Annual Dividend:$0.22
Dividend Yield:0.56%
Payout Ratio:31.88% (Trailing 12 Months of Earnings)
27.50% (Based on This Year's Estimates)
24.72% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Dividend History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for LeMaitre Vascular (NASDAQ:LMAT)
Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 66.34%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/30/2017David B RobertsInsiderSell26,683$36.67$978,465.61View SEC Filing  
8/30/2017George W LemaitreCEOSell15,000$37.13$556,950.00View SEC Filing  
8/29/2017George W LemaitreCEOSell15,000$36.72$550,800.00View SEC Filing  
8/28/2017George W LemaitreCEOSell30,000$36.43$1,092,900.00View SEC Filing  
8/25/2017George W LemaitreChairmanSell40,000$33.89$1,355,600.00View SEC Filing  
8/24/2017George W LemaitreCEOSell15,000$33.97$509,550.00View SEC Filing  
8/23/2017George W LemaitreCEOSell5,000$33.91$169,550.00View SEC Filing  
8/17/2017Lawrence J JasinskiDirectorSell2,030$34.23$69,486.90View SEC Filing  
8/11/2017George W LemaitreChairmanSell21,300$32.90$700,770.00View SEC Filing  
8/10/2017George W LemaitreCEOSell11,300$32.79$370,527.00View SEC Filing  
8/9/2017George W LemaitreChairmanSell30,000$33.65$1,009,500.00View SEC Filing  
8/8/2017George W LemaitreCEOSell10,000$34.02$340,200.00View SEC Filing  
8/7/2017George W LemaitreCEOSell10,000$33.62$336,200.00View SEC Filing  
8/7/2017Peter R GebauerInsiderSell6,224$33.85$210,682.40View SEC Filing  
8/4/2017David B RobertsInsiderSell48,317$33.12$1,600,259.04View SEC Filing  
8/3/2017George W LemaitreChairmanSell58,700$33.97$1,994,039.00View SEC Filing  
8/3/2017Peter R GebauerInsiderSell22,067$34.28$756,456.76View SEC Filing  
8/1/2017Lawrence J JasinskiDirectorSell6,500$34.47$224,055.00View SEC Filing  
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.32View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.40View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.75View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.47View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.56View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.39View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.24View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.60View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.70View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.00View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.00View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.00View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.00View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LeMaitre Vascular (NASDAQ:LMAT)
Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
americanbankingnews.com logoFinancial Analysis: LeMaitre Vascular (LMAT) vs. Its Rivals
www.americanbankingnews.com - October 18 at 6:36 AM
americanbankingnews.com logoLeMaitre Vascular (LMAT) versus The Competition Critical Review
www.americanbankingnews.com - October 17 at 12:54 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - October 17 at 6:26 AM
nasdaq.com logoLeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017 - Nasdaq
www.nasdaq.com - October 17 at 1:01 AM
finance.yahoo.com logoLeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017
finance.yahoo.com - October 16 at 7:59 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $25.42 Million
www.americanbankingnews.com - October 14 at 5:46 AM
americanbankingnews.com logoLeMaitre Vascular (LMAT) & Fulgent Genetic (FLGT) Head to Head Analysis
www.americanbankingnews.com - October 14 at 2:20 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Sees Large Increase in Short Interest
www.americanbankingnews.com - October 14 at 1:40 AM
americanbankingnews.com logo$0.20 EPS Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - October 12 at 12:26 PM
americanbankingnews.com logoLeMaitre Vascular's (LMAT) Hold Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - October 9 at 6:55 AM
finance.yahoo.com logoStocks With Rising Relative Strength: Penumbra
finance.yahoo.com - October 2 at 12:22 PM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 12:21 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 1 at 11:14 PM
americanbankingnews.com logoReviewing LeMaitre Vascular (LMAT) and Luna Innovations (LUNA)
www.americanbankingnews.com - September 28 at 4:30 AM
americanbankingnews.com logo$25.42 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - September 25 at 3:02 AM
nasdaq.com logo5 MedTech Stocks to Pick for Stellar Returns - Nasdaq
www.nasdaq.com - September 19 at 1:01 AM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017
finance.yahoo.com - September 15 at 6:06 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
finance.yahoo.com - September 14 at 7:15 AM
americanbankingnews.com logo Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) Will Post Quarterly Sales of $25.42 Million
www.americanbankingnews.com - September 7 at 11:30 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 10:42 PM
nasdaq.com logoForget Abbott, Buy These 4 High-Growth MedTech Stocks Instead - Nasdaq
www.nasdaq.com - September 6 at 9:43 PM
globenewswire.com logoLeMaitre Vascular to Present at Upcoming Investor Conferences - GlobeNewswire (press release)
globenewswire.com - September 5 at 9:04 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Insider Sells $978,465.61 in Stock
www.americanbankingnews.com - September 1 at 10:24 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO George W. Lemaitre Sells 15,000 Shares
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (LMAT) CEO Sells 15,000 Shares of Stock
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO Sells $1,092,900.00 in Stock
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO George W. Lemaitre Sells 5,000 Shares
www.americanbankingnews.com - August 25 at 8:32 PM
americanbankingnews.com logoGeorge W. Lemaitre Sells 40,000 Shares of LeMaitre Vascular, Inc. (LMAT) Stock
www.americanbankingnews.com - August 25 at 7:44 PM
nasdaq.com logoWhy LeMaitre Vascular (LMAT) Could Be Positioned for a Surge - Nasdaq
www.nasdaq.com - August 22 at 3:33 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Director Sells $69,486.90 in Stock
www.americanbankingnews.com - August 21 at 8:10 PM
zacks.com logoWhy LeMaitre Vascular (LMAT) Could Be Positioned for a Surge
www.zacks.com - August 21 at 8:26 AM
nasdaq.com logoLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 21, 2017 - Nasdaq
www.nasdaq.com - August 19 at 1:44 AM
thestreet.com logoReminder - LeMaitre Vascular (LMAT) Goes Ex-Dividend Soon
www.thestreet.com - August 18 at 8:43 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : August 14, 2017
finance.yahoo.com - August 15 at 1:04 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 12 at 10:50 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (LMAT) CEO Sells 11,300 Shares of Stock
www.americanbankingnews.com - August 11 at 7:54 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Chairman Sells $700,770.00 in Stock
www.americanbankingnews.com - August 11 at 7:52 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Insider Peter R. Gebauer Sells 6,224 Shares
www.americanbankingnews.com - August 9 at 9:04 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 10,000 Shares of Stock
www.americanbankingnews.com - August 9 at 8:46 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO George W. Lemaitre Sells 10,000 Shares
www.americanbankingnews.com - August 9 at 8:46 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Chairman Sells 30,000 Shares of Stock
www.americanbankingnews.com - August 9 at 7:52 PM
americanbankingnews.com logoDavid B. Roberts Sells 48,317 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 8 at 7:24 PM
americanbankingnews.com logoPeter R. Gebauer Sells 22,067 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 4 at 10:26 AM
americanbankingnews.com logoLawrence J. Jasinski Sells 6,500 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 3 at 10:38 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Chairman Sells 58,700 Shares of Stock
www.americanbankingnews.com - August 3 at 10:38 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : July 31, 2017
finance.yahoo.com - August 2 at 3:10 AM
americanbankingnews.com logoLeMaitre Vascular (NASDAQ:LMAT) versus Pacific Biosciences of California (PACB) Head to Head Contrast
www.americanbankingnews.com - July 31 at 12:25 PM
americanbankingnews.com logoEquities Analysts Offer Predictions for LeMaitre Vascular, Inc.'s Q3 2017 Earnings (LMAT)
www.americanbankingnews.com - July 31 at 7:45 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Buy Rating at Stifel Nicolaus
www.americanbankingnews.com - July 30 at 10:26 PM
americanbankingnews.com logo$0.20 Earnings Per Share Expected for LeMaitre Vascular, Inc. (NASDAQ:LMAT) This Quarter
www.americanbankingnews.com - July 30 at 10:24 AM



LeMaitre Vascular (LMAT) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.